Investor Presentation First Nine Months of 2022

63 Investor presentation First nine months of 2022 Global obesity market growth has been accelerating with Novo Nordisk capturing the majority of growth 80% 60% 40% 20% Obesity market growth and Novo Nordisk value market share Obesity market size and growth DKK billion 86% 180% 148% 140% 110% 100% 10.8 60% 11.7 ~110% 22.8 0.3 ~148% 86% 0% 20% 70% -20% -20% Aug Aug Aug NN Obesity care Others 2019 -NN market share 2022 2021 -Market growth (right axis) Novo Nordisk NN Growth (right axis) Source: IQVIA, Aug 2022 Value MAT, all countries; Share of growth not depicted due to high growth Aug 2022 Others Novo NordiskⓇ

View entire presentation